Perhaps prompted by all of the pet food recall announcements over the years, more and more companies and individuals have flooded the market with all natural and organic choices. For pet owners,…
The Food and Drug Administration is warning veterinarians and pet owners, particularly cat owners, of the possible risk of fractures with the Vet Jet™ transdermal vaccination system device. The device, made by Bioject, Inc., is sold exclusively as the delivery system for the Merial product, PUREVAX® Recombinant Feline Leukemia Vaccine. The device delivers the leukemia vaccine through the skin to cats.
The FDA (U.S. Food and Drug Administration) hosted a webinar today for pet health and safety bloggers. Featured speakers, Dr. Joshua Sharfstein, Principal Deputy Commissioner of the FDA, and Dr. Bernadette Dunham, Director of FDA’s Center for Veterinary Medicine, focused on the announcement of a widget containing information on the importance of pet health and safety for both animals and pet owners.
FDA’s Center for Veterinary Medicine Alerts Veterinarians About Problems with Vetsulin® to Treat Diabetes in Dogs and Cats
Nov 2, 2009: The Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) and Intervet/Schering-Plough Animal Health are alerting veterinarians and pet owners that Vetsulin®, a porcine insulin zinc suspension used to treat diabetes in animals, may have varying amounts of crystalline zinc insulin in the formulation.
Company fails to adhere to current Good Manufacturing Practice regulations
The U.S. Food and Drug Administration announced a consent decree of permanent injunction filed today, that prohibits Teva Animal Health Inc., its president, and two principals from its parent company, from manufacturing and distributing adulterated veterinary drugs. The injunction, once entered by the court, will prevent the defendants from manufacturing and distributing veterinary drugs until they achieve